RxDoctor Payments Data

Amanda Borrelli, DPM

Podiatrist · Hillsborough, NJNPI 1780171512

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (39.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 42.0% of the total. Reporting peaked in 2023 at $3,420 and has fallen 77.3% since, to $778 in 2025. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,295in general payments, 2019–2025

Across 70 payments — averaging $104.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Paragon 28, Inc.$2K
  • Stryker$849
  • Seapearl East, Inc$791
  • Medical Device Business Services, Inc.$350
  • Integra Lifesciences Corporation$218
  • plus $375 from 6 others

What the payments were for

  • Travel & lodging$2,65836%
  • Food & beverage$2,88340%
  • Education$1,55021%
  • Other$2043%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,295 in reported general payments places this provider in the 90th percentile of 382 podiatrist providers in New Jersey.

See all podiatrist providers in New Jersey

Medicare billing

Part B allowed, 2024
$245,812
Medicare patients
437
Services billed
2,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox69$2,128
CiclopiroxCiclopirox Olamine35$740
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip42$628
Ammonium Lactate63$540
Terbinafine Hcl41$318
Cephalexin26$271
Methylprednisolone29$200
Clotrimazole14$134
Gabapentin23$116
Meloxicam36$99
Mupirocin12$68
Naproxen15$44

Paid to pharmacies, not to this prescriber.

Other podiatrist in Hillsborough

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →